Microarray analysis in B cells among siblings with/without MS - role for transcription factor TCF2.

Area of Science:

• Immunology
• Genetics
• Neuroscience

Background:

• Multiple sclerosis (MS) is a complex neurological disease.
• Investigating genetic differences in B-lymphocytes may reveal disease mechanisms.
• Sibling studies can help differentiate genetic and environmental factors in MS.

Purpose of the Study:

• To compare global gene expression and transcription networks in B-lymphocytes between siblings with MS and healthy siblings.
• To identify specific genes and transcription factors with altered expression in MS.
• To explore the potential role of transcription factor 2 (TCF2) in MS pathogenesis.

Main Methods:

• Utilized virus-transformed immortalized B cells from siblings.
• Employed human whole genome bioarrays for gene expression analysis.
• Validated findings using reverse transcription quantitative polymerase chain reaction (RT-qPCR).

Main Results:

• Identified differential gene expression in B-lymphocytes of siblings with MS compared to healthy siblings.
• Observed upregulation of CXCL10, serpin B1, and FUT4, and downregulation of CDC5L, TNFRSF19, and HLA-DR.
• Discovered two intersecting transcription factor networks, one regulated by upregulated transcription factor 2 (TCF2) and another by downregulated CDC5L.

Conclusions:

• This study is the first to link TCF2 to multiple sclerosis (MS).
• Altered gene expression and transcription networks in B-lymphocytes suggest a role for TCF2 in MS.
• Further research in larger cohorts is necessary to elucidate the role of TCF2 in MS.